Back to search

Article

Apelin (APLN) is a biomarker contributing to the diagnosis and prognosis of hepatocellular carcinoma

2024-04-29

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Liver cancer, classified as a malignant hepatic tumor, can be divided into two categories: primary, originating within the liver, and secondary, resulting from metastasis to the liver from other organs. Hepatocellular carcinoma (HCC) is the main form of primary liver cancer and the third leading cause of cancer-related deaths. The diagnosis and prognosis of HCC u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ea06230-8cad-561e-96f0-15970efe543f
DOI
10.21203/rs.3.rs-4240806/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Apelin (APLN) is a biomarker contributing to the diagnosis and prognosis of hepatocellular carcinomaDOI 10.21203/rs.3.rs-4240806/v1
Novel hepatocellular carcinomas (HCC) Subtype-Specific BiomarkersSemantic proximity
Bioinformatics and machine learning driven key genes screening for hepatocellular carcinomaSemantic proximity
Screening of key variables and development and validation of a prognostic model for hepatocellular carcinomaSemantic proximity
Construction of a prognostic model for hepatocellular carcinoma patients through bioinformatics analysisSemantic proximity
The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinomaSemantic proximity
Genomic alterations in hepatocellular carcinoma patients undergoing liver transplantation predict recurrence and prognosisSemantic proximity
Kolmogorov-Arnold Network Model Integrated with Hypoxia Risk for Predicting PD-L1 Inhibitor Response in Hepatocellular CarcinomaSemantic proximity
Clinically Interpretable Extracellular Vesicle Gene Model for Non-Invasive Liver Cancer DiagnosisSemantic proximity
LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosisSemantic proximity
APLP2 as a Molecular Link Between Immune Regulation and Bone Metabolism in Hepatocellular Carcinoma: Evidence from scRNA-Seq and Functional ValidationSemantic proximity
An integrated model combined conventional radiomics and deep learning features to predict early recurrence of hepatocellular carcinoma eligible for curative ablation: a multicenter cohort studySemantic proximity
Machine learning predicts liver cancer risk from routine clinical data: a large population-based multicentric studySemantic proximity
Select a neighboring publication to make it the new centre.